22nd edition of the Grand Bal des Vins-Cœurs to benefit the Montreal Heart Institute Foundation

August 29, 2022
─

The 22nd edition of the Grand Bal des Vins-Cœurs will make its long-awaited in presence return to the city’s major philanthropic events on Thursday, September 8, at Windsor Station. The Montreal Heart Institute Foundation (MHIF) benefit event will gather close to 600 people from the Montreal business community around a common goal: to raise money to protect sensitive hearts.

During the event, the MHIF will pay tribute to an exceptional philanthropist, Mr. Jacques Goulet, a member of its Board of Directors and President of Sun Life Canada. As an agent of change, Mr. Goulet was instrumental in creating the Diabetes Prevention Clinic sponsored by Sun Life at the Montreal Heart Institute (MHI), which offers Canada’s only multidisciplinary type 2 diabetes prevention program.

“Type 2 diabetes affects nearly one in three Canadians, who unfortunately are more likely to develop cardiovascular health problems. I am committed to preventing type 2 diabetes which is why I have been involved with the Montreal Heart Institute Foundation for several years. I have nothing but praise for the team that supports patients in their efforts to lead a healthy life. The funds raised at this event will allow them to take even more action,” said Jacques Goulet, President of Sun Life Canada.

9 out of 10 Canadians over the age of 20 have at least one risk factor for cardiovascular disease

Whether in a suburban home, a downtown office, or a playground bench, no one is immune. Yet even though we know that cardiovascular disease is the number one cause of death in the world, we still take our hearts for granted. In fact, 9 out of 10 Canadians over the age of 20 have at least one risk factor for cardiovascular disease. These factors include a sedentary lifestyle, poor diet, stress, anxiety, overweight, smoking, cholesterol, and diabetes.

Reduce Cardiovascular Disease Incidents by Half by 2030

The MHI and its Foundation aim to reverse this trend by investing, thanks to generous donations, in cutting-edge fields that will help them achieve their ambition of halving the incidence of cardiovascular disease by 2030. Through scientific research, active prevention and precision medicine, the trend is to organize care around the patient and plan treatments precisely according to individual characteristics. These innovations will even make it possible to prevent cardiac events before they occur.

“A pioneer in genetic research and the personalization of care, the MHI is a leader in cardiovascular medicine. Thanks to the contributions of our donors each year, researchers can advance their work and push back the limits of cardiovascular medicine in order to offer patients the very best in care,” says Alain Gignac, President and CEO of the Montreal Heart Institute Foundation.

About the 22^nd edition of the Grand Bal des Vins-Cœurs

• Date: September 8, 2022, starting at 6:15 p.m.
• Cost: Various packages available starting at $1,800
• Location: Salle des Pas Perdus at Windsor Station, located at 1160 avenue des Canadiens-de-Montréal in Montreal

The Foundation thanks the Platinum Partners of the Grand Bal des Vins-Cœurs: Sun Life and Power Corporation of Canada.

About the Montreal Heart Institute Foundation

Created in 1977, the Montreal Heart Institute Foundation raises and manages funds to support the Institute’s innovative and priority projects and fight cardiovascular disease, the leading cause of death in the world. Its philanthropic events and donors’ contributions have enabled this leader in cardiovascular health to become the largest cardiac research centre in the country. Over the years, the Montreal Heart Institute Foundation has raised more than $350 million in donations. Its 27,822 donors have made it possible to make important discoveries and support the Institute’s specialists, professionals, and researchers to provide state-of-the-art care to tens of thousands of patients in Quebec.

About the Montreal Heart Institute

Founded in 1954, the Montreal Heart Institute constantly strives for the highest standards of excellence in the cardiovascular field through its leadership in clinical and fundamental research, ultra-specialized care, professional training, and prevention. It is home to Canada’s largest cardiology research centre, cardiovascular prevention centre, and cardiovascular genetics centre. The Institute is affiliated with the Université de Montréal and has more than 2,000 employees, including 245 physicians and more than 85 researchers.